메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

엘레바리스, EMEA 지역에 CDMO 서비스와 시술용 바늘 제품군 첫선

지금까지 쌓아온 깊은 신뢰와 전문성 홍보 차원에서 COMPAMED/MEDICA에 처음으로 출품 보스턴, 2025년 11월 4일 -- 미국의 스펙트라 메디컬 디바이시스(Spectra Medical Devices)가 영국의 XL 프리시전 테크놀로지스(XL Precision Technologies)를 인수하면서 탄생한 세계적인 '위탁 개발 및 제조 전문 기업(CDMO)' 엘레바리스 메디컬 디바이시스(Elevaris Medical Devices)가 유럽, 중동, 아프리카(EMEA) 지역에 처음으로 자사의 서비스와 시술용 바늘 제품군을 선보인다. 엘레바리스는 11월 17일부터 20일까지 뒤셀도르프에서 열리는 의료 기술 공급 분야를 전문으로 하는 유수의 국제 무역 박람회인 COMPAMED에 처음으로 참여할 예정이다. 엘레바리스 메디컬 디바이스의 리차드 즈레비에츠(Richard Zrebiec) 최고경영자(CEO)는 "엘레바리스는 상호 보완적인 기술력을 갖추고 오랜 세월 고객의 신뢰를 쌓아 온 두 회사를 합병했다. 내로라하는 의료기기 제조업체들이 자웅을 겨루는 유럽 최대의 박람회에 출품하게 되어 기대가 크다"라고
- 김갑성 기자
- 2025-11-04 17:00
The 5th World Health Forum Highlights Climate Change as a Defining Public Health Challenge

BEIJING, Nov. 4, 2025 -- The 5th World Health Forum convened in Beijing on November 1, gathering nearly 400 experts, scholars, and representatives from 22 countries and regions to explore new pathways for global health governance under the theme "Climate Change and Health: Responsibility, Governance and a Shared Future for Mankind." In his keynote address, Ban Ki-moon, Chairman of the Boao Forum for Asia and former UN Secretary-General, emphasized that climate change represents one of the most urgent public-health challenges of our time and called on the international communi
- 김갑성 기자
- 2025-11-04 16:49
Healthcare Holding Schweiz Acquires a Stake in QUNIQUE

Healthcare Holding Schweiz AG, a leading provider of medical technology services and distribution solutions in Switzerland, has expanded its portfolio through the acquisition of a stake in QUNIQUE GmbH. Healthcare Holding Schweiz is managed by Winterberg Advisory GmbH and KKA Partners. BAAR, Switzerland, Nov. 4, 2025 -- Healthcare Holding Schweiz AG has successfully acquired a stake in QUNIQUE GmbH, headquartered in Wohlen, thereby strengthening its expertise in regulatory affairs and quality management. In return, QUNIQUE's founder will reparticipate in the group. QUNIQUE is a
- 김갑성 기자
- 2025-11-04 16:00
NCCN Celebrates Expanding Access to Cancer Treatment in Africa at 2025 AORTIC Meeting with New NCCN Adaptations for Sub-Saharan Africa

[ 메디채널 김갑성 기자 ] Updated cancer treatment guidelines reflect significant progress in cancer care delivery through ongoing collaborative efforts to strengthen oncology resources across the region. HAMMAMET, Tunisia, Nov. 4, 2025 -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—collaborated with the African Cancer Coalition and the American Cancer Society to describe how cancer treatment guidelines have evolved across Sub-Saharan Africa in recent years, during the biannual African Organization for Research and Train
- 김갑성 기자
- 2025-11-04 15:06
AIA AND TOTTENHAM HOTSPUR FOOTBALL CLUB EXTEND PARTNERSHIP THROUGH TO 2032

Extension will mark nearly two decades of collaboration, making it one of the longest Premier League club sponsorships in history. AIA to become Global Training Partner of Tottenham Hotspur Football Club from July 2027. HONG KONG, Nov. 4, 2025 -- AIA Group Limited ("AIA" or the "Group") today announces that it will extend its successful association with Tottenham Hotspur Football Club ("Spurs" or "the Club"), becoming the Club's Global Training Partner from July 2027 through to June 2032. AIA remains the Club's Global Principal Par
- 황정호 기자
- 2025-11-04 14:52
Hasten Sets a New Benchmark for Global Expansion‌ by Building an End-to-End Asia-Pacific Healthcare Commercial Platform

SHANGHAI, Nov. 4, 2025 -- Hasten Biopharmaceutical Co., Ltd. ("Hasten") announced that while completing 70 Marketing Authorization Transfers (MAT) for its Asia-Pacific product portfolio, the company has established an end-to-end commercial network covering Southeast Asia, Australia, Korea, Hong Kong SAR and Taiwan, Province of China. This milestone marks Hasten successfully building a viable pan-Asia-Pacific commercial platform and setting a new benchmark for end-to-end global expansion of innovative biopharmaceuticals, which will benefit millions of chronic disease patients across
- 김갑성 기자
- 2025-11-04 11:15
Oral Presentation: Five Hematologic Malignancies Studies by Leads Biolabs to Be Featured at ASH 2025

NANJING, China, Nov. 4, 2025 -- Leads Biolabs (Stock Code: 9887.HK) today announced that five research abstracts from its hematological oncology portfolio—including programs LBL–034 and LBL–076—have been accepted for presentation at the 67th Annual Meeting of the American Society of Hematology (ASH), taking place December 6 to 9, 2025, in Orlando, Florida. These include one oral presentation, three poster presentations, and one online publication. LBL-034: Multiple Studies Featured, Clinical Data Highlighted in Oral Presentation Oral Presentation Title: A first-in-huma
- 김갑성 기자
- 2025-11-04 09:50
Therme Group Selected by Singapore Government to Build Asia's First State-of-the-Art Wellbeing Destination

Marina South Coast to be transformed into next-generation urban infrastructure, advancing wellbeing at scale, the Group's inaugural destination in Asia. SINGAPORE, Nov. 4, 2025 -- Therme Group, the leading global developer and operator of next-generation wellbeing destinations, today announced that it will be developing a S$1 billion state-of-the-art wellbeing oasis in Singapore, following the award of the Concept and Price Revenue Tender for a Wellness Attraction at the Marina South Coastal site by the Singapore Tourism Board (STB). This marks Therme Group's first foray into Singapore
- 김갑성 기자
- 2025-11-04 09:42
ICP DAS-BMP Redefines Medical Material Performance with Low-Migration and Low-Friction TPU at COMPAMED 2025

HSINCHU, Nov. 4, 2025 -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is pleased to announce its participation in COMPAMED 2025, taking place from November 17 to 20 at Messe Düsseldorf, Germany. Visitors can find the ICP DAS-BMP team at Hall 8b, Booth C09-4. The highlight of this year's exhibit will be two TPU innovations designed to address critical needs in medical device manufacturing: the Low-Migration Series and the Low-Friction Series. The low-migration Arothane™ ARP-B20
- 김갑성 기자
- 2025-11-04 08:45
ICP DAS-BMP, 컴파메드 2025에서 저이행성•저마찰 TPU로 의료용 소재 성능 재정의

신주 2025년 11월 4일 -- 대만의 의료용 열가소성 폴리우레탄(TPU) 제조•공급업체인 ICP DAS-BMP가 11월 17일부터 20일까지 독일 뒤셀도르프 메세 전시장에서 열리는 컴파메드 2025(COMPAMED 2025)에 참가한다고 발표했다. 방문객들은 홀 8b, C09-4 부스에서 ICP DAS-BMP 팀을 만날 수 있다. 올해 전시회의 하이라이트 중 하나는 의료기기 제조의 핵심 요구사항을 해결하기 위해 설계된 두 가지 TPU 혁신 제품인 Low-Migration 시리즈와 Low-Friction 시리즈다. 저이행성 Arothane™ ARP-B20 TPU는 ISO 10993을 준수하며 최대 90일간의 이식에 적합하다. 가공 중 첨가제 이행을 최소화해 카테터의 유통기한 동안 매끄러운 표면을 유지하는 동시에 유연하고 맞춤화된 설계를 위한 15가지 색상 옵션을 제공한다. 또 다른 핵심은 첫 선을 보이는 Low-Friction 시리즈로, 본질적으로 매끄러운 표면으로 설계되어 추가 코팅이나 후처리 공정이 필요하지 않다. Low-Friction 시리즈는 TPU로만 구성되어 과불화화합물(PFAS
- 김갑성 기자
- 2025-11-04 08:45

이전

51 52 53 54 55 56 57 58 59 60

많이 본 기사

최근기사

2026-01-01_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 01일 22시 40분